Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase 3 1Phase 2/3 1Phase 1 1

Status

Suspended 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Squamous Cell Carcinoma of Head and Neck 8Neoplasms 6Head and Neck Neoplasms 6Prostatic Neoplasms 5Oropharyngeal Neoplasms 5Lung Neoplasms 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Neoplasm Metastasis 4Myasthenia Gravis 4Lymphoma, Large B-Cell, Diffuse 4Cholangiocarcinoma 4Recurrence 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Mouth Neoplasms 3Leukemia, Myeloid, Acute 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Glioblastoma 3Fatigue 3Endometrial Neoplasms 3Carcinoma 3Breast Neoplasms 3Weight Loss 2Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Nasopharyngeal Carcinoma 2Melanoma 2

Interventions

Specimen Handling 1Radiotherapy 1Radiation 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1CTLA-4 Antigen 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Adenocarcinoma of Lung × 30 days × Clear all
NCT04929041 2026-05-13

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

National Cancer Institute (NCI)

Phase 2/3 Suspended
427 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡